Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.
Revenue of Sequent Scientific Limited (SEQUENT.NS)
Revenue in 2023 (TTM): $162.28 M
According to Sequent Scientific Limited's latest financial reports the company's current revenue (TTM) is $162.28 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Sequent Scientific Limited
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $162.28 M | $35.29 M | $6.51 M | $-6,474,331 | $-4,249,676 |
| 2022 | $168.35 M | $69.56 M | $-5,503,051 | $-16,309,519 | $-14,354,744 |
| 2021 | $167.07 M | $67.03 M | $14.25 M | $6.33 M | $4.85 M |
| 2020 | $160.19 M | $72.92 M | $25.07 M | $16.19 M | $11.31 M |
| 2019 | $137.49 M | $61.86 M | $21.37 M | $11.15 M | $8.28 M |
| 2018 | $120.91 M | $52.85 M | $15.83 M | $6.98 M | $5.77 M |
| 2017 | $99.75 M | $42.52 M | $11.62 M | $2.8 M | $49.95 M |
| 2016 | $105.97 M | $48.6 M | $6.4 M | $75.59 K | $-1,637,835 |
| 2015 | $74.59 M | $32.66 M | $7.57 M | $-2,009,855 | $-2,624,991 |
| 2014 | $52.21 M | $21.51 M | $1.35 M | $-7,501,888 | $-1,272,213 |
| 2013 | $53.76 M | $20.05 M | $-4,535,444 | $-13,022,356 | $-13,090,954 |
| 2012 | $38.63 M | $13.51 M | $-1,267,356 | $-8,619,251 | $-7,664,795 |
| 2011 | $40.97 M | $18.22 M | $5.63 M | $-641,320 | $-165,750 |
| 2010 | $36.93 M | $17.73 M | $5.11 M | $413.37 K | $-20,852 |
| 2009 | $33.7 M | $18.58 M | $10.08 M | $4.68 M | $4.43 M |
| 2008 | $17.06 M | $9.18 M | $-131,510 | $-1,497,676 | $-1,736,764 |
| 2007 | $8.86 M | $2.4 M | $1.02 M | $439.33 K | $298.78 K |
| 2006 | $5.3 M | $1.7 M | $1.5 M | $1.32 M | $1.02 M |